Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 8Uterine Cervical Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumor, Pleural 1Rectal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuroblastoma 1Neoplasms 1Muscle-invasive Bladder Cancer 1Mouth Neoplasms 1Mesothelioma, Malignant 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Brain Neoplasms 1Body Weight Changes 1

Interventions

Mirtazapine 4Megestrol Acetate 4nabiximols 1anamorelin 1Watchful Waiting 1Thalidomide 1Olanzapine 1Observation 1Megestrol 1Infliximab 1Gemcitabine 1Flurandrenolone 1EOM613 1Dronabinol 1Dexamethasone 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anorexia × Watchful Waiting × Clear all
NCT01200602 2015-11-25

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Mayo Clinic

Phase 2 Terminated
1 enrolled

Anorexia, Body Weight Changes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡